Institutional Fund
Atlas Venture Life Science Advisors, LLC
Cambridge, MACIK 19175295 filings on record
Portfolio Value
$790.03M
Q1 2026
Holdings
6
Reported positions
New Buys
0
Opened this quarter
QoQ Change
-8.7%
from $865.15M
Portfolio Value Trend
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeTop Allocations
Largest positions by weight
- Kymera Therapeutics Inc48.3%
- Dyne Therapeutics Inc21.0%
- Sionna Therapeutics Inc15.2%
- Disc Medicine Inc12.3%
- Q32 Bio Inc1.7%
- Korro Bio Inc1.6%
Portfolio Holdings
6 positions · Q1 2026
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Kymera Therapeutics Inc | 4.58M | $381.30M | 48.3% | −81.9K | Reduced |
| 2 | Dyne Therapeutics Inc | 9.13M | $165.54M | 21.0% | 0 | Held |
| 3 | Sionna Therapeutics Inc | 3.00M | $120.09M | 15.2% | 0 | Held |
| 4 | Disc Medicine Inc | 1.51M | $96.80M | 12.3% | 0 | Held |
| 5 | Q32 Bio Inc | 2.09M | $13.43M | 1.7% | 0 | Held |
| 6 | Korro Bio Inc | 1.14M | $12.87M | 1.6% | 0 | Held |